These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 10233765)

  • 1. The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic.
    Ding X; Diaz LA; Fairley JA; Giudice GJ; Liu Z
    J Invest Dermatol; 1999 May; 112(5):739-43. PubMed ID: 10233765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles.
    Ding X; Aoki V; Mascaro JM; Lopez-Swiderski A; Diaz LA; Fairley JA
    J Invest Dermatol; 1997 Oct; 109(4):592-6. PubMed ID: 9326396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subset of pemphigus foliaceus patients exhibits pathogenic autoantibodies against both desmoglein-1 and desmoglein-3.
    Arteaga LA; Prisayanh PS; Warren SJ; Liu Z; Diaz LA; Lin MS;
    J Invest Dermatol; 2002 May; 118(5):806-11. PubMed ID: 11982757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies.
    Hacker MK; Janson M; Fairley JA; Lin MS
    Clin Immunol; 2002 Oct; 105(1):64-74. PubMed ID: 12483995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
    Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
    J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal pemphigus vulgaris: IgG4 autoantibodies to desmoglein 3 induce skin blisters in newborns.
    Parlowsky T; Welzel J; Amagai M; Zillikens D; Wygold T
    J Am Acad Dermatol; 2003 Apr; 48(4):623-5. PubMed ID: 12664033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus.
    Futei Y; Amagai M; Ishii K; Kuroda-Kinoshita K; Ohya K; Nishikawa T
    J Dermatol Sci; 2001 May; 26(1):55-61. PubMed ID: 11323221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
    Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
    J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic and histopathologic characterization of an active disease mouse model for pemphigus vulgaris.
    Ohyama M; Amagai M; Tsunoda K; Ota T; Koyasu S; Hata J; Umezawa A; Nishikawa T
    J Invest Dermatol; 2002 Jan; 118(1):199-204. PubMed ID: 11851895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against desmoglein 2 are not pathogenic in pemphigus.
    Miguel MCB; Julio TA; Vernal S; de Paula NA; Lieber A; Roselino AM
    An Bras Dermatol; 2022; 97(2):145-156. PubMed ID: 35058080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pemphigus foliaceus and pemphigus vulgaris autoantibodies react with the extracellular domain of desmoglein-1.
    Emery DJ; Diaz LA; Fairley JA; Lopez A; Taylor AF; Giudice GJ
    J Invest Dermatol; 1995 Mar; 104(3):323-8. PubMed ID: 7860995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin is an additional immunological target for pemphigus autoantibodies.
    Evangelista F; Dasher DA; Diaz LA; Prisayanh PS; Li N
    J Invest Dermatol; 2008 Jul; 128(7):1710-8. PubMed ID: 18219275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-desmoglein 1 antibodies in Tunisian healthy subjects: arguments for the role of environmental factors in the occurrence of Tunisian pemphigus foliaceus.
    Kallel Sellami M; Ben Ayed M; Mouquet H; Drouot L; Zitouni M; Mokni M; Cerruti M; Turki H; Fezza B; Mokhtar I; Ben Osman A; Zahaf A; Kamoun MR; Joly P; Masmoudi H; Makni S; Tron F; Gilbert D
    Clin Exp Immunol; 2004 Jul; 137(1):195-200. PubMed ID: 15196262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of non-pathogenic human monoclonal antibodies to desmoglein 3 from pemphigus vulgaris patient.
    Bhol KC; Ahmed AR
    Autoimmunity; 2002 Mar; 35(2):87-91. PubMed ID: 12071440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris.
    Mimouni D; Blank M; Payne AS; Anhalt GJ; Avivi C; Barshack I; David M; Shoenfeld Y
    Clin Exp Immunol; 2010 Dec; 162(3):543-9. PubMed ID: 20964642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous pemphigus vulgaris with absence of desmoglein 1 autoantibodies. An example of the extended desmoglein compensation theory.
    Carew B; Wagner G
    Australas J Dermatol; 2014 Nov; 55(4):292-5. PubMed ID: 25399788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a new antibody population directed against a desmosomal plaque antigen in pemphigus vulgaris and pemphigus foliaceus.
    Joly P; Gilbert D; Thomine E; Zitouni M; Ghohestani R; Delpech A; Lauret P; Tron F
    J Invest Dermatol; 1997 Apr; 108(4):469-75. PubMed ID: 9077476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of pemphigus antigens in drug-induced pemphigus vulgaris and pemphigus foliaceus.
    Brenner S; Bialy-Golan A; Anhalt GJ
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):919-23. PubMed ID: 9204055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris.
    Chernyavsky A; Amber KT; Agnoletti AF; Wang C; Grando SA
    J Biol Chem; 2019 Mar; 294(12):4520-4528. PubMed ID: 30692201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.